Institute of Medicine recommends US FDA reforms

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1559, 2006-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Report on Drug Safety and the US FDA by the Institute of Medicine

By Fox Anthony W.

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 5, 2006-01 ,pp. : 289-291

Adis International

Access to resources Recommend Favorite

Institute of Medicine: FDA should tighten postmarketing activities

Reactions Weekly, Vol. 1, Iss. 1401, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A US FDA advisory committee recommends that alosetron [`Lotronex'; GlaxoSmithKline] be reintroduced

Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

US-style Institute of Medicine needed in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

FDA recommends changes to TNF antagonist labels

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite